Brennan M.

Brennan Munley is an experienced professional in business development and regulatory affairs, currently serving as the Director of Business Development at Rho since August 2021, where the focus is on addressing the clinical and regulatory challenges faced by small biotech companies, particularly in neuropsychiatric, analgesic, respiratory, and dermatologic therapeutics. Prior to this role, Brennan held positions at Parexel, achieving recognition as the 2020 Global Business Development "Rookie of the Year" and contributing significantly to securing $525 million in potential work through extensive client engagement. Brennan's earlier experience includes a role at AstraZeneca, where compliance with GDPR was assessed, and work as an Immunotherapy Research Assistant at Michigan Medicine, focused on cancer immunotherapy research. Brennan holds a Master of Science in Biotechnology from Georgetown University and a Bachelor of Science in Biochemistry from the University of Michigan.